A team at the American Association of Physicists in Medicine (AAPM) has received a $250,000 Eugene Washington PCORI Engagement Award from the Patient-Centered Outcomes Research Institute (PCORI). The ...

Approximately one in eight men will develop prostate cancer, which is the second-leading cause of cancer death in American men and typically affects patients who are 65 or older. Fortunately, the ...

After skin cancer, prostate cancer is the most commonly diagnosed cancer among men in the United States. In fact, one in eight men will be diagnosed with prostate cancer during their lifetime, ...

In the modern diagnostic and therapeutic nuclear medicine, radiopharmaceuticals are successfully used for the diagnosis and, increasingly, for the treatment of diseases. Despite the increasing benefit ...

Radiation is a century-old tool in fighting cancer. In recent years, scientists have sharpened its focus, to attack tumors without damaging the body around it. In this week's Moves in Medicine, we ...

A series of developments from 1954 through 1972 marked the transition to adoption of the linear, no-threshold model as a predictive model of radiation injury in exposed populations. In 1954, the ...

A Philadelphia-area startup is developing a device to reduce radiation doses used to conduct medical procedures such as cardiac catheterization and orthopedic surgery. Company name: IntelliRad Control ...

Coverage from the Institute for Value-Based Medicine event in Tampa, Florida, with Moffitt Cancer Center. At a recent event held by The American Journal of Managed Care Institute for Value-Based ...

When a medical imaging exam provides a clinical benefit, the only risk that should be considered is the exam itself rather than a patient's previous radiation exposure, according to a statement by ...

Physicians from the UAB Department of Radiation Oncology are bringing advanced cancer care closer to home for patients in east Alabama through their ongoing partnership with Russell Medical Center ...

Cardiac tumours in veterinary patients, though relatively rare, pose significant diagnostic and therapeutic challenges. These neoplasms can originate primarily in the heart or emerge as secondary ...